Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes

To assess the effects of proprotein convertase subtilisin/kexin type 9 inhibitor (evolocumab) on lipoprotein particles subfractions with Nuclear Magnetic Resonance spectroscopy in patients with acute coronary ...

Source: BMC Cardiovascular Disorders - January 7, 2021 Category: Cardiology Authors: Tingting Li, Yingyi Zhang and Hongliang Cong Tags: Research article Source Type: research